USHealthcare

Elanco Animal Health (ELAN)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$25.60-0.47%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.37B
Revenue YoY
+14.9%
Net profit
$57.0M
Profit YoY
-14.9%
EPS
$0.40
EPS estimate
$0.34
Net margin
4.2%

EPS came in at 0.40 against a street estimate of 0.34 — a beat of 17.6%.

Key statistics

Market cap
$13.17B
Forward P/E
24.0
P/B
2.03
Book value
$13.02
EPS (TTM)
$-0.50
52-week high
$27.72
52-week low
$13.76
50-day MA
$24.40
200-day MA
$23.46
Beta
1.69

Analyst view

Analysts rate Elanco Animal Health a buy (7 buy, 8 hold, 0 sell out of 15) with an average price target of $30.07.

Shareholding

Insiders
1.22%
Institutions
111.39%

Largest institutional holders

FundStake
Dodge & Cox13.80%
FMR Inc10.20%
BlackRock Inc9.54%
PRIMECAP Management Company9.18%
T. Rowe Price Investment Management,Inc.6.93%
Dimensional Fund Advisors, Inc.4.91%
Vanguard Portfolio Management, LLC4.53%
Vanguard Capital Management, LLC4.47%

Recent filings & reports

DocumentDate
Shareholder vote results · Q2 20262026-05-27
Quarterly report · Q1 20262026-05-06
Results announced · Q2 20262026-05-06
Proxy statement · Q4 20252026-04-08
Annual report FY20252026-02-24
Results announced · Q1 20262026-02-24
Reg FD disclosure · Q1 20262026-01-12
Quarterly report · Q3 20252025-11-05

Readable in the app.

Deals & corporate news

AnnouncementDate
Full year and Q2 2026 guidance provided for fiscal quarter ended March 31
Elanco Animal Health Incorporated filed an 8-K on May 6, 2026, announcing Q1 2026 earnings results and providing guidance for the full year and Q2 2026. The filing itself contains minimal de
2026-05-06
Full year and Q1 2026 guidance provided for animal health company
Elanco Animal Health Incorporated filed an 8-K on February 24, 2026, announcing its full-year and fourth-quarter 2025 financial results, along with 2026 guidance. The 8-K itself contains no
2026-02-24
Q3 2025 results and full year guidance for 2025 provided
Elanco Animal Health Incorporated filed an 8-K on November 5, 2025, announcing its third quarter fiscal 2025 results (ended September 30, 2025) and providing full-year and fourth quarter 202
2025-11-05
Q2 2025 results and full year, Q3 2025 guidance provided
Elanco Animal Health Incorporated filed an 8-K on August 7, 2025, disclosing Q2 2025 (quarter ended June 30, 2025) financial results and providing guidance for the full year 2025 and Q3 2025
2025-08-07

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Elanco Animal Health — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-08-05.